Xilio TherapeuticsXLO
那斯達克 · USD
0.60
+0.06
(+11.44%)
收盤 02/13 04:56 (UTC+8)
盤後
0.56
0.56
(-5.66%)
02/13 04:56 (UTC+8)
Xilio TherapeuticsXLO
0.60
+0.06
(+11.44%)
財務數據
損益表
- -
- -
- -
- -
- 0.02
- 0.02
- 0.02
- 0.03
- 0.08
- 0.19
- -
- -
- -
- -
- -
- -3.99
- -23.82
- 69.95
- 175.90
- 135.85
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 19,066 | 8,084 | 2,930 | 1,724 | 2,263 | 2,357 | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 19,066 | 8,084 | 2,930 | 1,724 | 2,263 | 2,357 | - | - | - | - |
營業費用 | 20,995 | 22,450 | 16,781 | 15,353 | 17,025 | - | - | 18,130 | 17,361 | 20,116 |
研發費用 | 14,321 | 15,330 | 8,266 | 8,836 | 10,759 | 11,216 | 10,400 | 11,736 | 11,051 | 13,218 |
推銷及管理費用 | 6,674 | 7,120 | 8,515 | 6,517 | 6,307 | 5,815 | 6,139 | 6,394 | 6,310 | 6,898 |
非經常性項目費用 | - | - | - | - | -41 | 30 | 948 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,929 | -14,366 | -13,851 | -13,629 | -14,762 | -14,704 | -17,487 | -18,130 | -17,361 | -20,116 |
其他收入及費用 | -14,358 | - | 586 | 536 | 742 | 779 | 284 | 475 | 613 | 761 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -16,287 | -15,844 | -13,265 | -13,093 | -14,020 | -13,925 | -17,203 | -17,655 | -16,748 | -19,355 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -16,287 | -15,844 | -13,265 | -13,093 | -14,020 | -13,925 | -17,203 | -17,655 | -16,748 | -19,355 |
基本每股稅後盈餘(元) | -0.11 | -0.16 | -0.18 | -0.20 | -0.22 | -0.24 | -0.62 | - | -0.61 | -0.70 |
稀釋每股稅後盈餘(元) | -0.09 | -0.16 | -0.18 | -0.18 | -0.18 | -0.11 | -0.62 | -0.64 | -0.61 | -0.70 |
基本平均股數(千股) | 144106.00 | 96447.00 | 74700.00 | 64675.00 | 63465.00 | 57760.00 | 27912.00 | - | 27523.00 | 27468.00 |
稀釋平均股數(千股) | 144106.00 | 96447.00 | 74700.00 | 64675.00 | 63465.00 | 57760.00 | 27912.00 | - | 27523.00 | 27468.00 |
還原基本每股稅後盈餘(元) | -0.11 | -0.16 | -0.18 | -0.20 | -0.22 | -0.24 | -0.62 | - | -0.61 | -0.70 |
還原稀釋每股稅後盈餘(元) | -0.09 | -0.16 | -0.18 | -0.18 | -0.18 | -0.11 | -0.62 | -0.64 | -0.61 | -0.70 |
還原基本平均股數(千股) | 144,106 | 96,447 | 74,700 | 64,675 | 63,465 | 57,760 | 27,912 | - | 27,523 | 27,468 |
還原稀釋平均股數(千股) | 144,106 | 96,447 | 74,700 | 64,675 | 63,465 | 57,760 | 27,912 | - | 27,523 | 27,468 |
EBITDA(千元) | -15,947 | -15,463 | -12,768 | -12,717 | -13,639 | -13,480 | -16,760 | -17,206 | -16,288 | -18,863 |